527 related articles for article (PubMed ID: 26120905)
1. Acute in vivo toxicity mitigation of PEI-coated maghemite nanoparticles using controlled oxidation and surface modifications toward siRNA delivery.
Israel LL; Lellouche E; Ostrovsky S; Yarmiayev V; Bechor M; Michaeli S; Lellouche JP
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15240-55. PubMed ID: 26120905
[TBL] [Abstract][Full Text] [Related]
2. Unique Surface Modification of Silica Nanoparticles with Polyethylenimine (PEI) for siRNA Delivery Using Cerium Cation Coordination Chemistry.
Kapilov-Buchman Y; Lellouche E; Michaeli S; Lellouche JP
Bioconjug Chem; 2015 May; 26(5):880-9. PubMed ID: 25830668
[TBL] [Abstract][Full Text] [Related]
3. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
[TBL] [Abstract][Full Text] [Related]
4. MagRET Nanoparticles: An Iron Oxide Nanocomposite Platform for Gene Silencing from MicroRNAs to Long Noncoding RNAs.
Lellouche E; Israel LL; Bechor M; Attal S; Kurlander E; Asher VA; Dolitzky A; Shaham L; Izraeli S; Lellouche JP; Michaeli S
Bioconjug Chem; 2015 Aug; 26(8):1692-701. PubMed ID: 26056709
[TBL] [Abstract][Full Text] [Related]
5. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.
Zintchenko A; Philipp A; Dehshahri A; Wagner E
Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894
[TBL] [Abstract][Full Text] [Related]
6. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
[TBL] [Abstract][Full Text] [Related]
7. Polymeric nanoparticles for siRNA delivery and gene silencing.
Patil Y; Panyam J
Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242
[TBL] [Abstract][Full Text] [Related]
8. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.
Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155
[TBL] [Abstract][Full Text] [Related]
9. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
[TBL] [Abstract][Full Text] [Related]
10. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery.
Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG
J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409
[TBL] [Abstract][Full Text] [Related]
11. Facile hydrothermal synthesis and surface functionalization of polyethyleneimine-coated iron oxide nanoparticles for biomedical applications.
Cai H; An X; Cui J; Li J; Wen S; Li K; Shen M; Zheng L; Zhang G; Shi X
ACS Appl Mater Interfaces; 2013 Mar; 5(5):1722-31. PubMed ID: 23388099
[TBL] [Abstract][Full Text] [Related]
12. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
13. Ce
Israel LL; Lellouche E; Kenett RS; Green O; Michaeli S; Lellouche JP
J Mater Chem B; 2014 Oct; 2(37):6215-6225. PubMed ID: 32262139
[TBL] [Abstract][Full Text] [Related]
14. Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery.
Peng SF; Hsu HK; Lin CC; Cheng YM; Hsu KH
Molecules; 2017 Jan; 22(1):. PubMed ID: 28054985
[TBL] [Abstract][Full Text] [Related]
15. Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles.
Zhang H; Lee MY; Hogg MG; Dordick JS; Sharfstein ST
ACS Nano; 2010 Aug; 4(8):4733-43. PubMed ID: 20731451
[TBL] [Abstract][Full Text] [Related]
16. Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis.
Duan J; Dong J; Zhang T; Su Z; Ding J; Zhang Y; Mao X
Nanomedicine (Lond); 2014 May; 9(6):789-801. PubMed ID: 24392891
[TBL] [Abstract][Full Text] [Related]
17. Aggregation control of hydrophilic maghemite (gamma-Fe2O3) nanoparticles by surface doping using cerium atoms.
Haviv AH; Grenèche JM; Lellouche JP
J Am Chem Soc; 2010 Sep; 132(36):12519-21. PubMed ID: 20735060
[TBL] [Abstract][Full Text] [Related]
18. The PEI-introduced CS shell/PMMA core nanoparticle for silencing the expression of E6/E7 oncogenes in human cervical cells.
Saengkrit N; Sanitrum P; Woramongkolchai N; Saesoo S; Pimpha N; Chaleawlert-Umpon S; Tencomnao T; Puttipipatkhachorn S
Carbohydr Polym; 2012 Oct; 90(3):1323-9. PubMed ID: 22939347
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.
Wang G; Kucharski C; Lin X; Uludağ H
J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316
[TBL] [Abstract][Full Text] [Related]
20. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
